USDA Responds to New World Screwworm; New Case Confirmed in La Salle County, Texas
On Jun. 9, 2026, The U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS), alongside…
-
-
Artificial Intelligence | Biotechnology | Clinical Research | Genomics | Pharmaceutical | Therapeutics
Google DeepMind, Google.org and Sanger Institute to launch new AI consortium for genomics
On Jun. 8, 2026, the Wellcome Sanger Institute, Google.org, and Google DeepMind announced they are partnering up to…
-
Incyte to Acquire Vega Therapeutics, Subsidiary of Star Therapeutics, for $1.25 billion, Expanding its Hematology Portfolio into Bleeding Disorders
On Jun. 8, 2026, Incyte announced it has entered into a definitive agreement to acquire Vega Therapeutics, a wholly owned…
-
Johnson & Johnson to Acquire Firefly Bio for $1 Billion in Cash to Expand Oncology Pipeline
On Jun. 8, 2026, Johnson & Johnson announced it has entered into a definitive agreement to acquire Firefly…
-
Roche announces global collaboration with Nurix Therapeutics worth up to $2.3 billion
On Jun. 7, 2026, Roche announced that it has entered into an exclusive licensing and collaboration agreement with…
-
study finds Indoor air contains greater diversity of airborne fungi than previously thought
On Jun. 5, 2026, researchers from Imperial College London have conducted the UK’s largest-ever longitudinal study of indoor…
-
Debugging California: Fighting mosquitoes with mosquitoes
On Jun. 4, 2026, a program called Debug—run by Google’s health research arm—has applied to the EPA to…
-
Caught in the act: a gene jumps into the void
On Jun. 4, 2026, scientists from the Max Planck Institute report that genes are not passed on exclusively…
-
Bioprinting Cartilage, Producing Stem Cells Fill ISS Research Schedule
On Jun. 4, 2026, 3D bioprinting and stem cell research were the main research topics aboard the International…
-
Lilly gains license for Ascidian’s gene-editing tech to develop kidney disease drugs worth up to $1.9 billion
On Jun. 3, 2026, Ascidian Therapeutics said it has signed a licensing deal for its gene-editing technology with…
-
Flesh-eating screwworm may have been detected in South Texas, USDA says
On Jun. 3, 2026, an infestation of the flesh-eating screwworm parasite may have been detected in South Texas,…
-
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics Worth Up to $2 Billion
On Jun. 3, 2026, Alnylam Pharmaceuticals, the leading RNAi therapeutics company, and Inceptive Nucleics, which builds foundation models…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | Measles | NIH | Vaccine
Measles cases mount in Florida, highest number reported in 25 years
On Jun. 2, 2026, The Florida Department of Health said there have been 154 measles cases in the…
-
Microrobots repair spinal cord
On Jun. 2, 2026, a research team from ETH Zurich and the University of Zurich (UZH) announced it…
-
CEPI funds next phase of nanoparticle vaccine platform to support rapid outbreak response
On Jun. 2, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) announced New funding will support the continued…
-
CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates
On May 31, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) announced it will urgently accelerate development of…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | Measles | NIH | Vaccine
U.S. nears 2,000 measles cases as scientists note brain inflammation, pneumonia in hospital cases
On May 29, 2026, the U.S. Centers for Disease Control and Prevention (CDC) confirmed 31 new measles cases…
-
New study explores potential cross-species spread of chronic wasting disease
On May 28, 2026, In a newly published study in Science Advances, researchers from the University of Calgary and collaborators…
-
Unilever Investing $270 Million in Global Innovation Centre in New Haven, Connecticut
On May 28, 2026, Unilever unveiled plans to develop a new Global Innovation Centre in New Haven, Connecticut,…
-
Pfizer and China’s Innovent Biologics Enter Global Strategic Collaboration worth $9.85 billion to Accelerate Development of Oncology Medicines
On May 28, 2026, Pfizer and Innovent Biologics announced the companies have entered into a strategic global licensing…
-
Can an Alzheimer’s Blood Test Detect Early, Subtle Cognitive Decline?
On May 28, 2026, the University of California, San Francisco (UCSF) announced that for the first time, researchers…
-
Scientists Map Proteins From Billion-Year-Old Organism and Discover New Links to Rare Diseases
On May 27, 2026, a University of Texas at Austin-led team has identified genes by comparing groups of…
-
Abbott secures CE Mark for world’s first dual glucose-ketone sensing technology for people with diabetes
On May 27, 2026, Abbott announced it has secured CE Mark for the world’s first dual glucose‑ketone sensing…
-
New MRI sensors developed at MIT sensitively detect target molecules in the brain and body.
On May 27, 2026, researchers at Massachusetts Institute of Technology announced that MRI can noninvasively capture detailed images…
-
Lilly announces three acquisitions to build infectious disease portfolio for $3.8 Billion in Cash
On May 26, 2026, Eli Lilly announced agreements to acquire three companies, Curevo, LimmaTech Biologics, and Vaccine Company,…
-
New kidney stone treatment powered by biomedical engineering research receives FDA approval
On May 25, 2026, Virginia Tech researchers announced they have received Food and Drug Administration (FDA) approval for…
-
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus
On May 22, 2026, Gilead Sciences announced announced that the U.S. Food and Drug Administration (FDA) has granted…
-
Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer
On May 22, 2026, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
-
Engage Bio Acquired by Lilly for $202 million in cash to Accelerate Development of Non-Viral Genetic Medicines
On May 20, 2026, Engage Biologics, a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it…
-
Biotechnology | Cloning | CRISPR | Environmental | Genomics
Artificial Womb Construction Nearing Completion
On May 19, 2026, Colossal Biosciences announced it is developing a functional artificial womb capable of growing a…
